Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data

PURPOSE: Despite the poor prognosis of triple-negative breast cancer (TNBC), it has been demonstrated that neoadjuvant immunotherapy in combination with chemotherapy can improve the pathologic complete response (pCR) rate and/or long-term outcome of TNBC. However, there have been no real-world studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Heran, Wang, Liying, Wang, Na, Zhang, Kejin, Zhao, Yanxia, Qiu, Pengfei, Qi, Xiaowei, Zhang, Danhua, Xu, Fei, Liu, Jieqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826585/
https://www.ncbi.nlm.nih.gov/pubmed/36611131
http://dx.doi.org/10.1186/s12885-023-10515-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826585/
https://www.ncbi.nlm.nih.gov/pubmed/36611131
http://dx.doi.org/10.1186/s12885-023-10515-z

Ejemplares similares